1. Home
  2. CYRX vs HPF Comparison

CYRX vs HPF Comparison

Compare CYRX & HPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYRX
  • HPF
  • Stock Information
  • Founded
  • CYRX 1999
  • HPF 2002
  • Country
  • CYRX United States
  • HPF United States
  • Employees
  • CYRX N/A
  • HPF N/A
  • Industry
  • CYRX Biotechnology: Pharmaceutical Preparations
  • HPF Finance Companies
  • Sector
  • CYRX Health Care
  • HPF Finance
  • Exchange
  • CYRX Nasdaq
  • HPF Nasdaq
  • Market Cap
  • CYRX 365.5M
  • HPF 341.3M
  • IPO Year
  • CYRX N/A
  • HPF N/A
  • Fundamental
  • Price
  • CYRX $7.55
  • HPF $15.84
  • Analyst Decision
  • CYRX Strong Buy
  • HPF
  • Analyst Count
  • CYRX 9
  • HPF 0
  • Target Price
  • CYRX $10.67
  • HPF N/A
  • AVG Volume (30 Days)
  • CYRX 554.6K
  • HPF 35.3K
  • Earning Date
  • CYRX 08-05-2025
  • HPF 01-01-0001
  • Dividend Yield
  • CYRX N/A
  • HPF 8.96%
  • EPS Growth
  • CYRX N/A
  • HPF N/A
  • EPS
  • CYRX N/A
  • HPF N/A
  • Revenue
  • CYRX $232,134,000.00
  • HPF N/A
  • Revenue This Year
  • CYRX N/A
  • HPF N/A
  • Revenue Next Year
  • CYRX $9.63
  • HPF N/A
  • P/E Ratio
  • CYRX N/A
  • HPF N/A
  • Revenue Growth
  • CYRX 11.75
  • HPF N/A
  • 52 Week Low
  • CYRX $4.58
  • HPF $12.99
  • 52 Week High
  • CYRX $9.78
  • HPF $16.80
  • Technical
  • Relative Strength Index (RSI)
  • CYRX 59.40
  • HPF 48.23
  • Support Level
  • CYRX $7.20
  • HPF $15.90
  • Resistance Level
  • CYRX $7.81
  • HPF $16.20
  • Average True Range (ATR)
  • CYRX 0.40
  • HPF 0.13
  • MACD
  • CYRX 0.01
  • HPF 0.03
  • Stochastic Oscillator
  • CYRX 77.22
  • HPF 42.86

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

About HPF John Hancock Pfd Income Fund II Pfd Income Fund II

John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.

Share on Social Networks: